MARKET

TMO

TMO

Thermo Fishr Sci
NYSE
579.46
+0.09
+0.02%
Opening 13:02 03/28 EDT
OPEN
579.30
PREV CLOSE
579.37
HIGH
582.30
LOW
576.19
VOLUME
318.20K
TURNOVER
0
52 WEEK HIGH
603.82
52 WEEK LOW
415.05
MARKET CAP
220.96B
P/E (TTM)
37.50
1D
5D
1M
3M
1Y
5Y
Danaher: All In On Life Sciences, And Market Update
Danaher Corporation (DHR) is a leading player in the life science industry. The healthcare industry is facing challenges due to weak funding and high vacancy rates in lab spaces. Danaher has spun-off three companies in the past 10 years. The company has a strong financial performance despite many spin-offs.
Seeking Alpha · 1d ago
Thermo Fisher Scientific (TMO) Falls More Steeply Than Broader Market: What Investors Need to Know
NASDAQ · 1d ago
Tracking Chris Hohn's TCI Fund Management 13F Portfolio - Q4 2023 Update
TCI Fund Management's 13F portfolio value increased from $27.56B to $35.97B this quarter. The top three holdings in the portfolio are General Electric, Canadian National Railway, and Moody's. The fund established a new stake in Microsoft Corporation and increased their stakes in Moody's Corp and Alphabet Inc.
Seeking Alpha · 2d ago
The Health Care Select Sector SPDR Fund Experiences Big Outflow
NASDAQ · 3d ago
QIAGEN (QGEN) Partners With IPPA to Raise TB Screening Awareness
NASDAQ · 3d ago
Weekly Report: what happened at TMO last week (0318-0322)?
Weekly Report · 3d ago
GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive
GE Healthcare Technologies Inc. Is expected to experience good revenue and margin growth moving forward. The company's revenue growth will be supported by pent-up demand for procedures and strong end-market demand. New product innovations and a tuck-in M&A strategy will also contribute to sales growth. GEHC stock is trading at a significant discount to its peers with similar growth prospects. I continue to have a buy rating on the stock.
Seeking Alpha · 3d ago
U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies -- Heard on the Street
Congress is considering a bill to blacklist certain Chinese biotech companies. U.S. Companies have outsourced contract manufacturing and research to Chinese companies. The bill could have unintended consequences for companies that rely on those companies for drug development. Congress is considering the legislation to protect national-security concerns.
The Wall Street Journal · 5d ago
More
About TMO
Thermo Fisher Scientific Inc. is engaged in helping life sciences research, increasing laboratory productivity, and improving patient health through diagnostics and the development and manufacture of life-changing therapies. The Company's Life Sciences Solutions segment provides a portfolio of reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines as well as diagnosis of infection and disease. Analytical Instruments segment provides instruments and the supporting consumables, software and services that are used for a range of applications in the laboratory and in the field. Specialty Diagnostics segment offers a range of diagnostic test kits, reagents, culture media, instruments and associated products to serve customers in healthcare, clinical, pharmaceutical, industrial, and food safety laboratories. The Laboratory Products and Biopharma Services segment offers virtually everything needed for the laboratory.

Webull offers Thermo Fisher Scientific Inc stock information, including NYSE: TMO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TMO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TMO stock methods without spending real money on the virtual paper trading platform.